Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-19-019942

President and CEO gave up 5,343 shares (to pay taxes)

  • President and CEO acquired 15,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-31 Exercise or conversion : show line 1 in the form +15,450 150,517 D
2019-12-31 Shares withheld for taxes : show line 2 in the form −5,343 $0.89 $4,755 145,174 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-31 Exercise or conversion : show line 3 in the form Restricted Stock Units −15,450 154,500 D
Loading xslF345X03/ownership.xml…